Achieve Life Sciences (ACHV) Other Non-Current Assets (2010 - 2026)
Achieve Life Sciences (ACHV) posted Other Non-Current Assets of $265000.0 for Q1 2026, up 409.62% on a QoQ basis from $52000.0 in Q4 2025, and down 11.67% year-over-year from $300000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $265000.0 for Q1 2026.
- Quarterly Other Non-Current Assets fell 11.67% year-over-year to $265000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $265000.0 (down 11.67% YoY) and the FY2025 annual result came in at $52000.0, up 33.33% from the prior year.
- Other Non-Current Assets was $265000.0 for Q1 2026 at Achieve Life Sciences, up from $52000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $304000.0 in Q3 2024 and bottomed at $39000.0 in Q4 2024.
- A 5-year average of $145058.8 and a median of $99000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets surged 310.81% — and 2025, when it tumbled 78.62%.
- Achieve Life Sciences' Other Non-Current Assets stood at $123000.0 in 2022, then dropped by 25.2% to $92000.0 in 2023, then sank by 57.61% to $39000.0 in 2024, then soared by 33.33% to $52000.0 in 2025, then soared by 409.62% to $265000.0 in 2026.
- Business Quant data shows ACHV's Other Non-Current Assets at $265000.0 in Q1 2026, $52000.0 in Q4 2025, and $65000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | 265,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 265,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 39,000.00 |
| Sep 30, 2024 | 304,000.00 |
| Jun 30, 2024 | 117,000.00 |
| Mar 31, 2024 | 94,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Sep 30, 2023 | 74,000.00 |
| Jun 30, 2023 | 99,000.00 |
| Mar 31, 2023 | 68,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Sep 30, 2022 | 239,000.00 |
| Jun 30, 2022 | 240,000.00 |
| Mar 31, 2022 | 253,000.00 |
| Dec 31, 2021 | 183,000.00 |
| Sep 30, 2021 | 235,000.00 |
| Jun 30, 2021 | 227,000.00 |